Clinical trial

Regenerative Cellular Therapies, Physiology, Pathology and Developmental Biology

NCT02469207

StatusUNKNOWN

Study typeOBSERVATIONAL

Start date2016-01-01

PhaseN/A

Study timeline

Study start (unknown)2016-01-01Date precision: month

Registry last updated2016-07-14

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Graft Rejectionunresolved

Transplantationunresolved

Diabetes Mellitusunresolved

Interventions

Removal of tissue post-mortemOTHER

Sponsors & collaborators

Cambridge University Hospitals NHS Foundation Trustlead sponsor

University of Cambridgecollaborator

Cambridge Stem Cell Institute, Cambridgecollaborator

Anne McLarent Laboratory of Regenerative Medicine, Cambridgecollaborator

The Gurdon Institute, Cambridgecollaborator

Sanger Institure, Cambridgecollaborator

Institute of Metabolic Science, Cambridgecollaborator

MRC Mitochondrial Biology Unit, Cambridgecollaborator

Mapped research locations

CambridgeUnited Kingdom1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02469207 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.